Background: Both Indole-amine-2,3-dioxygenase (IDO) and neutrophils were proved to have pro-tumor effect in some kinds of solid tumors by immune suppression.
| INTRODUC TI ON
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. 1 Although a growing number of molecular-targeted drugs and immune therapy proved can be of benefit in part of patients with advanced HCC, the high price and low objective response rate make majority of patients cannot benefit from them. 2 It is of great importance to seek optimal biomarkers to improve the outcome of advanced HCC.
Indole-amine-2,3-dioxygenase (IDO) is responsible for the first enzymatic step of tryptophan catabolism by the kynurenine pathway performed as the rate-limiting enzyme. Protein expression of IDO was found to be high in a number of tumor samples and contribute to decrease patient survival. 3, 4 IDO expression in various histologic cancer types seems to build an immune-suppressive microenvironment 5, 6 by regulating immune cells such as T effector cells, 7 Treg cells, 8 and MDSC. 9, 10 On the other hand, several studies have provided compelling evidence for pro-tumor functions of neutrophils by immune suppression. 11, 12 However, little was known about the relationship between IDO and neutrophils while tumor-associated neutrophils (TANs) were found in various human cancers. 13, 14 In this study, we investigated the prognostic significance of IDO and intra-tumoral neutrophils in HCC patients and explored the correlation between IDO and intra-tumoral neutrophils. The study was approved by the research ethics committee of Zhongshan Hospital.
| ME THODS

| Study population
| TMA and immunohistochemical staining
Two cylinders of the tumor tissue were included in each case in TMA to ensure reproducibility and homogeneity. Intra-tumoral neutrophils were evaluated by immunohistochemical staining of CD66b, which was a marker mainly expressed by human neutrophils. 15, 16 A two-step method of immunohistochemistry (IHC) including a heatinduced antigen-retrieval procedure was performed. The primary antibodies used were anti-CD66b antibody (1:50, abcam) and anti-IDO antibody (1:150, abcam). Microarrays were evaluated at 400× magnification light microscopy by pathologists blinded to the clinic pathologic data of the patients. IDO staining was evaluated by a score calculated by multiplying the staining extent score (0: 0%-5%, 1: 6%-25%, 2: 25%-50%, 3: >50%) with the staining intensity score (0: no staining, 1: weak, 2: strong, 3: very strong), resulting in a low (0-4) expression level or a high (>4) level for each case by mean value of two spots. CD66b staining was determined as negative or positive.
| Statistical analysis
Analysis was performed with SPSS 19.0 for Windows (SPSS, Chicago, IL). All consecutive data were expressed as mean ± standard deviation. Correlations between immunostaining parameters and clinic pathologic features were analyzed by χ 2 test and Fisher's exact probability test as appropriate. Univariate and multivariate analysis were carried out with the Kaplan-Meier method and the Cox proportional hazards regression model and was compared with the log-rank test. P < 0.05 was considered statistically significant.
| RE SULTS
| Prognostic factors for HCC patients after resection
The 1-, 3-, 5-, 7-years survival rates for 153 HCC patients after resection were 84%, 66%, 59% and 50%, respectively. Representative images of IDO and CD66b were shown in Figure 1 . Univariate analysis showed that serum AFP level (more than 20 ng/mL) before resection, tumor diameter (more than 10 cm),with thrombus (portal vein), high Edmonson stage (stage 3-4), high IDO expression, and intro-tumoral neutrophils infiltration were prognostic factors for OS after resection (Table 1 ).Multivariate analysis showed high IDO expression (HR = 1.793, P = 0.028), intra-tumoral neutrophils infiltration (HR = 2.159, P = 0.001), with thrombus (HR = 2.526, P = 0.000), and high Edmonson stage (HR = 1.848, P = 0.014) were independent prognostic factors for OS ( Figure 2 ).
| Correlation between IDO and intra-tumoral neutrophils
To further understand the effect of IDO for HCC and its' correlation with intra-tumoral neutrophils, we compared clinical characteristics and percentages of patients with intra-tumoral neutrophils infiltra- (Table 2 ). However, it showed significant difference in percentages of patients with intro-tumoral neutrophil infiltration between these two groups. In high IDO expression group, the percentage of intra-tumoral neutrophils infiltration was 45.26%, much higher than that in low IDO expression group (27.59%, P = 0.022, 
| D ISCUSS I ON
The results of this study showed that both high IDO expression
and intra-tumoral neutrophils infiltration were independent prognostic factors for poor survival for HCC patients. There are three Trp-catabolic enzymes (IDO1, IDO2, and TDO) in mammals which catalyze conversion of the essential amino acid tryptophan (Trp) to kynurenine (Kyn). In humans, IDO1 shows a high protein expression in the peripheral lymph organs, while IDO2 and TDO show high tissue specificity and much lower expression level than IDO1 that significantly restrict their activity. 6, 17 The "IDO" we discussed in this study was IDO1. In patients with solid tumors, such as colorectal cancer, small cell lung cancer, melanoma, and ovarian cancer, high IDO expression is correlated with a poor prognosis and shorter overall survival. 18, 19 In HCC, IDO was expressed in HCC cells following the stimulation of IFN-γ, 20 and our study confirmed that high IDO expression was a prognostic factor for poor survival for HCC patients. immune responses, 9, 10 inhibits the surface expression of activating receptors and regulates NK-cell function. 22, 23 There is strong evidence that suppression of antitumor immune responses by IDO would make such catabolism an attractive target for therapeutic intervention. 24 Clinical evidence indicates that neutrophils are involved in tumor progression. A negative correlation between the number of tumorassociated neutrophils and prognosis has been evidenced for many types of cancer including renal carcinoma, 25 colorectal cancer, 26 gastric cancer, 27 HCC, 28 and non-small cell lung cancer. 29 Our results showed that intra-tumoral neutrophils infiltration was an independent prognostic factor for poor survival for HCC patients, which is consistent with previous results. Furthermore, we found that the percentage of intra-tumoral neutrophils infiltration was much higher in high IDO expression group than that in low IDO expression group. 
